Jazz Pharmaceuticals has announced that it has commenced construction of a manufacturing and development facility to be located on a 17-acre site in Monksland, County Roscommon, approximately 75 miles east of the company's Dublin headquarters.
This is the first manufacturing facility to be built by Jazz Pharmaceuticals.
"Today marks a milestone for Jazz Pharmaceuticals as we break ground in Ireland and begin, for the first time, construction on a manufacturing and development facility," said Bruce Cozadd, Chairman and Chief Executive Officer of Jazz Pharmaceuticals plc. "This investment not only strengthens our international manufacturing capabilities, but importantly represents our commitment to expanding our presence in Ireland. We are grateful for the partnership of IDA Ireland and Roscommon County Council who helped make this project possible."
Members of the Board of Directors and employees of Jazz Pharmaceuticals were joined by the Taoiseach of Ireland, Mr Enda Kenny TD and Mr Barry O'Leary, CEO, IDA Ireland, during a ground-breaking ceremony today. At the ceremony, Mr Cozadd outlined the company's plans to commence construction immediately, with an anticipated completion date in 2016. Jazz Pharmaceuticals expects to invest approximately $60 – $68m (€45 – €50m) in construction, development and personnel costs to build and open the 55,000 ft2 (5,100 m2) facility.
The investment is being supported by the Irish Government's Department of Jobs, Enterprise and Innovation through IDA Ireland.
(CD/JP)
Ireland
UK
Scotland
London










![PEFC [Ireland] Ltd](http://www.construction.co.uk/advnew/588433bul.jpg)
